SMMTSummit Therapeutics Inc.Feb 24, 2026Q4 2025
Read transcript →Summit Therapeutics Inc. (SMMT) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$14.08
+7.61%
Mkt Cap $10.94B
SMMTSummit Therapeutics Inc.Feb 24, 2026SMMTSummit Therapeutics Inc.Oct 20, 2025Q3 2025
Read transcript →SMMTSummit Therapeutics Inc.May 2, 2025Q1 2025
Read transcript →SMMTSummit Therapeutics Inc.Feb 24, 2025Q4 2024
Read transcript →SMMTSummit Therapeutics Inc.Oct 30, 2024Q3 2024
Read transcript →SMMTSummit Therapeutics Inc.May 1, 2024Q1 2024
Read transcript →SMMTSummit Therapeutics Inc.Feb 20, 2024Q4 2023
Read transcript →SMMTSummit Therapeutics Inc.Nov 7, 2023Q3 2023
Read transcript →SMMTSummit Therapeutics Inc.Aug 9, 2023Q2 2023
Read transcript →SMMTSummit Therapeutics Inc.May 11, 2023Q1 2023
Read transcript →SMMTSummit Therapeutics Inc.Mar 10, 2023Q4 2022
Read transcript →SMMTSummit Therapeutics Inc.Oct 11, 2019Q2 2019
Read transcript →SMMTSummit Therapeutics Inc.Mar 27, 2019Q4 2018
Read transcript →SMMTSummit Therapeutics Inc.Sep 20, 2018Q2 2018
Read transcript →SMMTSummit Therapeutics Inc.Apr 11, 2018Q4 2017
Read transcript →SMMTSummit Therapeutics Inc.Aug 31, 2017Q2 2017
Read transcript →SMMTSummit Therapeutics Inc.Mar 29, 2017Q4 2016
Read transcript →SMMTSummit Therapeutics Inc.Sep 14, 2016Q2 2016
Read transcript →SMMTSummit Therapeutics Inc.May 10, 2016Q4 2015
Read transcript →